Trials / Completed
CompletedNCT01033799
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (actual)
- Sponsor
- Danone Global Research & Innovation Center · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This single-center, randomized, double-blind and controlled study aims to examine the effect of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel® = tested product) on the incidence of respiratory and gastro-intestinal common infectious diseases (cumulated number of infections during the intervention period: primary criteria), and on immune functions in healthy shift workers. Volunteers received either 200g/day of tested product (N=500) or control product (N=500) for 3-months, followed by a 1-month follow-up.
Conditions
- Infectious Diseases
- Healthy Subjects
- Respiratory Tract Infections
- Sore Throat
- Sinusitis
- Otitis
- Bronchitis
- Pneumonia
- Influenza
- Gastroenteritis
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®) | |
| OTHER | Non fermented dairy product (control) |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-04-01
- Completion
- 2007-08-01
- First posted
- 2009-12-17
- Last updated
- 2017-01-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01033799. Inclusion in this directory is not an endorsement.